Search Results - "Varnäs, K."
-
1
Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect
Published in The international journal of neuropsychopharmacology (01-05-2024)“…Major depressive disorder (MDD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs). SSRIs inhibit the serotonin transporter (5-HTT), but…”
Get full text
Journal Article -
2
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [11C]AZ10419369 Positron Emission Tomography Study
Published in The international journal of neuropsychopharmacology (17-04-2023)“…Abstract Background The serotonin system has been implicated in several psychiatric disorders. All major psychiatric disorders are associated with cognitive…”
Get full text
Journal Article -
3
Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676
Published in The Journal of pharmacology and experimental therapeutics (01-09-2016)“…Positron emission tomography (PET) is widely applied in central nervous system (CNS) drug development for assessment of target engagement in vivo. As the…”
Get more information
Journal Article -
4
P.1.g.069 Relationship between dose, plasma concentration and GABA-A receptor occupancy by partial GABA-A receptor modulators
Published in European neuropsychopharmacology (01-09-2015)Get full text
Journal Article -
5
Amphetamine decreases binding of the novel alpha2C-adrenoreceptor radioligand [11C]ORM-13070 in monkey brain
Published in NEUROIMAGE (01-08-2010)“…Initial characterization of [11C]ORM-13070 has been performed in rat and human and has indicated that [11C]ORM-13070 binds selectively to the…”
Get full text
Journal Article Conference Proceeding -
6
145. Translocator protein (TSPO) as a biomarker of microglia activation: PET imaging using [11C]PBR28 in Parkinson’s disease
Published in Brain, behavior, and immunity (01-09-2013)“…Positron emission tomography (PET) studies in Parkinson’s’ disease (PD) using the radioligand [11C]PK11195 have demonstrated increased binding to TSPO, in…”
Get full text
Journal Article -
7
11 Early clinical development of amyloid-beta specific PET radioligand [18F]AZD4694
Published in Neurobiology of aging (01-05-2012)Get full text
Journal Article -
8
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data
Published in NeuroImage (Orlando, Fla.) (01-06-2016)“…The human brainstem is a complex structure with several small nuclei and neural pathways of interest in the pathophysiology of central nervous system (CNS)…”
Get full text
Journal Article -
9
-
10
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain
Published in Human brain mapping (01-07-2004)“…Several neurochemical in vitro and in vivo imaging studies have been aimed at characterizing the localization of serotonin receptors and transporters in the…”
Get full text
Journal Article Conference Proceeding -
11
Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder – a pilot study
Published in Psychiatry research. Neuroimaging (30-09-2017)“…Highlights • Verbal fluency improved after Internet-based CBT in patients with MDD. • Significant correlations were found between cognitive ability and 5-HT1BR…”
Get full text
Journal Article -
12
-
13
New halogenated [11c]WAY analogues, [11C]6FPWAY and [11c]6bpway-radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey
Published in Nuclear medicine and biology (01-02-2001)“…[Carbonyl-(11)C]WAY-100635 ([(11)C]WAY) is an established radioligand for the study of brain serotonin(1A) (5-HT(1A)) receptors in living animals and humans…”
Get full text
Journal Article -
14
Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT 1A receptor and the alpha1-adrenergic receptor
Published in Nuclear medicine and biology (2002)“…This paper reports the synthesis, biological evaluation, in vitro and ex vivo autoradiography of the first Tc-99m ligand with subnanomolar affinity for the…”
Get full text
Journal Article -
15
The 5-HT 1B receptor - a potential target for antidepressant treatment
Published in PSYCHOPHARMACOLOGY (01-05-2018)“…Major depressive disorder (MDD) is the leading cause of disability worldwide. The serotonin hypothesis may be the model of MDD pathophysiology with the most…”
Get full text
Journal Article -
16
Candidate genes and brain cortical morphology in schizophrenia
Published in EUROPEAN PSYCHIATRY (2008)Get full text
Journal Article Conference Proceeding -
17
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743
Published in Brain research (05-10-2001)“…The distribution of 5-HT(1B) and 5-HT(1D) receptors in the human post mortem brain was examined using whole hemisphere autoradiography and the radioligand…”
Get full text
Journal Article -
18
Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non‐human primate and human brain
Published in Synapse (New York, N.Y.) (01-10-2020)“…Synaptic vesicle glycoprotein 2A (SV2A) has been previously characterized as an imaging biomarker for assessment of synaptic density in positron emission…”
Get full text
Journal Article -
19
The 5-HT1B receptor - a potential target for antidepressant treatment
Published in Psychopharmacology (01-05-2018)“…Major depressive disorder (MDD) is the leading cause of disability worldwide. The serotonin hypothesis may be the model of MDD pathophysiology with the most…”
Get full text
Journal Article -
20
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
Published in Clinical cancer research (15-10-2016)“…Approximately one-third of patients with non-small cell lung cancer (NSCLC) harboring tumors with EGFR-tyrosine kinase inhibitor (TKI)-sensitizing mutations…”
Get full text
Journal Article